Life Care News
A Hope Of True Information

KemPharm Receives FDA Orphan Drug Designation for Serdexmethylphenidate (SDX) for the Treatment of Idiopathic Hypersomnia (IH)


Phase 2 clinical trial investigating KP1077 in patients with IH expected to initiate prior to year-end 2022

Get real time updates directly on you device, subscribe now.

Has Aji River now become a dumping site?